Follow
Jitinder Singh Wilkhu
Jitinder Singh Wilkhu
PhD in Drug Delivery, Aston University
Verified email at aston.ac.uk
Title
Cited by
Cited by
Year
Microscopy imaging of liposomes: from coverslips to environmental SEM
S Bibi, R Kaur, M Henriksen-Lacey, SE McNeil, J Wilkhu, E Lattmann, ...
International journal of pharmaceutics 417 (1-2), 138-150, 2011
1392011
The application of monolayer studies in the understanding of liposomal formulations
B Moghaddam, MH Ali, J Wilkhu, DJ Kirby, AR Mohammed, Q Zheng, ...
International journal of pharmaceutics 417 (1-2), 235-244, 2011
622011
Characterization and optimization of bilosomes for oral vaccine delivery
JS Wilkhu, SE McNeil, DE Anderson, Y Perrie
Journal of drug targeting 21 (3), 291-299, 2013
572013
Effect of incorporating cholesterol into DDA: TDB liposomal adjuvants on bilayer properties, biodistribution, and immune responses
R Kaur, M Henriksen-Lacey, J Wilkhu, A Devitt, D Christensen, Y Perrie
Molecular pharmaceutics 11 (1), 197-207, 2014
552014
Formulation design considerations for oral vaccines
J Wilkhu, SE McNeil, DJ Kirby, Y Perrie
Therapeutic delivery 2 (9), 1141-1164, 2011
372011
Cannabinoid formulations
J Wilkhu, J Bender
US Patent App. 15/640,033, 2018
292018
Investigating the role of cholesterol in the formation of non-ionic surfactant based bilayer vesicles: thermal analysis and molecular dynamics
JS Wilkhu, D Ouyang, MJ Kirchmeier, DE Anderson, Y Perrie
International journal of pharmaceutics 461 (1-2), 331-341, 2014
282014
Development of a solid dosage platform for the oral delivery of bilayer vesicles
JS Wilkhu, SE McNeil, DE Anderson, M Kirchmeier, Y Perrie
European Journal of Pharmaceutical Sciences 108, 71-77, 2017
182017
Methods for preparing vesicles and formulations produced therefrom
DE Anderson, Y Perrie, M Kirchmeier, JS Wilkhu
US Patent App. 13/979,317, 2013
102013
Parenteral formulations
S Wright, J Wilkhu
US Patent 11,229,612, 2022
92022
Consideration of the efficacy of non-ionic vesicles in the targeted delivery of oral vaccines
JS Wilkhu, SE McNeil, DE Anderson, Y Perrie
Drug delivery and translational research 4 (3), 233-245, 2014
92014
Oral cannabinoid formulations
S Wright, J Wilkhu
US Patent App. 16/486,750, 2019
82019
Oral pharmaceutical formulation comprising cannabinoids and poloxamer
J Wilkhu, J Bender
US Patent App. 16/959,357, 2021
72021
Pharmaceutical composition comprising a cannabinoid
J Wilkhu, J Bender
US Patent App. 16/959,350, 2021
72021
Modified release composition comprising a cannabinoid
J Wilkhu, J Bender, M Collins
US Patent App. 16/959,354, 2021
72021
Non-ionic surfactant technology for the delivery and administration of sub-unit flu antigens
J Wilkhu
Aston University, 2013
52013
Developing Bilayer-Based Delivery Systems for Oral Delivery of Subunit Vaccines
JS Wilkhu, Y Perrie
Subunit Vaccine Delivery, 95-123, 2015
22015
Designing nonionic surfactant vesicles for the delivery of antigens for systemic and alternative delivery routes
J Wilkhu, A Vangala, AR Mohammed, Y Perrie
Immunomic Discovery of Adjuvants and Candidate Subunit Vaccines, 205-232, 2013
22013
Cannabinoid formulations
A Silcock, J Wilkhu
US Patent App. 17/615,422, 2022
2022
Cannabinoid formulations
J Wilkhu, A Silcock
US Patent App. 17/406,401, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20